C WorldWide Group Holding A S cut its stake in shares of Glaukos Corporation (NYSE:GKOS) by 28.5% during the second quarter, Holdings Channel reports. The institutional investor owned 257,831 shares of the medical instruments supplier’s stock after selling 102,977 shares during the period. C WorldWide Group Holding A S’s holdings in Glaukos Corporation were worth $10,692,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in GKOS. Great West Life Assurance Co. Can acquired a new position in shares of Glaukos Corporation during the first quarter worth about $102,000. Prudential Financial Inc. acquired a new position in shares of Glaukos Corporation during the first quarter worth about $204,000. State Board of Administration of Florida Retirement System raised its position in shares of Glaukos Corporation by 1.9% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 7,699 shares of the medical instruments supplier’s stock worth $264,000 after buying an additional 140 shares during the period. Caxton Associates LP acquired a new position in shares of Glaukos Corporation during the first quarter worth about $272,000. Finally, Engineers Gate Manager LP acquired a new position in shares of Glaukos Corporation during the first quarter worth about $372,000. Institutional investors own 89.63% of the company’s stock.

Shares of Glaukos Corporation (GKOS) opened at 36.31 on Friday. Glaukos Corporation has a one year low of $28.26 and a one year high of $52.49. The firm’s market capitalization is $1.25 billion. The company’s 50 day moving average price is $40.56 and its 200 day moving average price is $43.21.

WARNING: This piece was first published by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/glaukos-corporation-nysegkos-position-reduced-by-c-worldwide-group-holding-a-s/1474465.html.

GKOS has been the subject of several recent research reports. Zacks Investment Research downgraded Glaukos Corporation from a “buy” rating to a “hold” rating in a report on Monday. Roth Capital decreased their price target on Glaukos Corporation from $60.00 to $54.00 and set a “buy” rating for the company in a report on Thursday, August 3rd. Piper Jaffray Companies reaffirmed a “buy” rating and set a $56.00 price target on shares of Glaukos Corporation in a report on Thursday, August 3rd. Finally, BidaskClub downgraded Glaukos Corporation from a “hold” rating to a “sell” rating in a report on Saturday, August 5th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and seven have assigned a buy rating to the company’s stock. Glaukos Corporation has an average rating of “Buy” and an average target price of $52.33.

Glaukos Corporation Company Profile

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm’s canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream.

Want to see what other hedge funds are holding GKOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Glaukos Corporation (NYSE:GKOS).

Institutional Ownership by Quarter for Glaukos Corporation (NYSE:GKOS)

Receive News & Ratings for Glaukos Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.